StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) stock

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$40.49−1.76 (-4.17%)

Close on Nov 17, 2026Market cap $116.37MP/E –Yield –

Spruce Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Spruce Biosciences's price to book ratio was 1.5× on Nov 11, 2026, against 10.5× a year earlier. Over the last 5 years it ranged from 0.3× to 32.8×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−7.6
2025Dec 31, 20259.1×+8.8
2024Dec 31, 20240.3×−1.1
2023Dec 29, 20231.4×+1.1
2022Dec 30, 20220.3×−0.5
2021Dec 31, 20210.9×–

More Spruce Biosciences figures

See a number that looks wrong?